Now is the time
for pharmaceutical and biotech companies, both large and small, to assess their current sample management strategies to ensure current and future drug
discovery is not jeopardized by sub-optimal management processes or samples or lack of sample data.
Explore how emerging in vitro systems — built from primary cells, cocultures, and vascularized tissues — are improving translational research outcomes.